glp 1 regulations FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Report: FDA must enforce rules

In plain terms, it may help patients who feel like their eating is less about physical hunger and more about urges, stress, or emotional triggers

While some individuals may notice initial changes in appetite and a small amount of weight loss within the first few weeks, significant and sustained weight loss generally unfolds over several months

Starting at a low dose of 0.25 mg in the first week is a crucial step to minimize potential gastrointestinal side effects that many patients experience when beginning treatment with semaglutide GLP-1

Most elective surgery patients can safely continue treatment with safeguards

1 Schematic representation of the distribution of glucagon-like peptide-1 (GLP-1) receptors (GLP-1Rs) and the cardiovascular and systemic effects of GLP-1